AlphaCrest Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,883
| Closed | -$658K | – | 494 |
|
|
2022
Q3 | $658K | Buy |
+8,883
| New | +$658K | 0.04% | 849 |
|
|
2022
Q2 | – | Sell |
-3,209
| Closed | -$203K | – | 1295 |
|
|
2022
Q1 | $203K | Sell |
3,209
-8,957
| -74% | -$567K | 0.01% | 1207 |
|
|
2021
Q4 | $645K | Buy |
+12,166
| New | +$645K | 0.02% | 999 |
|
|
2021
Q3 | – | Sell |
-3,410
| Closed | -$227K | – | 1295 |
|
|
2021
Q2 | $227K | Sell |
3,410
-2,123
| -38% | -$141K | 0.01% | 1176 |
|
|
2021
Q1 | $614K | Buy |
5,533
+1,377
| +33% | +$153K | 0.03% | 708 |
|
|
2020
Q4 | $494K | Buy |
+4,156
| New | +$494K | 0.04% | 658 |
|
|
2020
Q3 | – | Sell |
-3,339
| Closed | -$299K | – | 1136 |
|
|
2020
Q2 | $299K | Buy |
3,339
+604
| +22% | +$54.1K | 0.05% | 630 |
|
|
2020
Q1 | $273K | Sell |
2,735
-854
| -24% | -$85.2K | 0.03% | 830 |
|
|
2019
Q4 | $412K | Buy |
3,589
+484
| +16% | +$55.6K | 0.03% | 904 |
|
|
2019
Q3 | $392K | Buy |
+3,105
| New | +$392K | 0.02% | 1024 |
|
|
2019
Q2 | – | Sell |
-5,182
| Closed | -$453K | – | 1071 |
|
|
2019
Q1 | $453K | Buy |
+5,182
| New | +$453K | 0.07% | 500 |
|